国际免疫学杂志2024,Vol.47Issue(1) :74-78.DOI:10.3760/cma.j.issn.1673-4394.2024.01.013

多发性硬化损伤的免疫机制研究进展

Research progress on the immune mechanism of multiple sclerosis injury

于倩 赵琳琳 何敏 张惊宇
国际免疫学杂志2024,Vol.47Issue(1) :74-78.DOI:10.3760/cma.j.issn.1673-4394.2024.01.013

多发性硬化损伤的免疫机制研究进展

Research progress on the immune mechanism of multiple sclerosis injury

于倩 1赵琳琳 1何敏 1张惊宇1
扫码查看

作者信息

  • 1. 哈尔滨医科大学附属第四医院神经内科,哈尔滨 150001
  • 折叠

摘要

多发性硬化(multiple sclerosis,MS)是中枢神经系统慢性自身免疫性炎性脱髓鞘疾病。既往研究主要探讨T淋巴细胞在MS中的作用,但近年来越来越多的证据表明B淋巴细胞在该病发生发展中发挥了重要作用。文章对T淋巴细胞、B淋巴细胞及细胞因子参与MS的发病机制及相关治疗药物进行概述,以期为MS的治疗提供新的思路。 Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating disease of the central nervous system. Previous studies have mainly explored the role of T lymphocytes in MS, but in recent years, more and more evidences have shown that B lymphocytes play an important role in the occurrence and development of this disease. This review summarizes the role of T lymphocytes, B lymphocytes, and cytokines in pathogenesis of MS and related therapeutic drugs, in order to provide new ideas for the treatment.

Abstract

Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating disease of the central nervous system. Previous studies have mainly explored the role of T lymphocytes in MS, but in recent years, more and more evidences have shown that B lymphocytes play an important role in the occurrence and development of this disease. This review summarizes the role of T lymphocytes, B lymphocytes, and cytokines in pathogenesis of MS and related therapeutic drugs, in order to provide new ideas for the treatment.

关键词

多发性硬化/T淋巴细胞/B淋巴细胞/细胞因子

Key words

Multiple sclerosis/T lymphocytes/B lymphocytes/Cytokine

引用本文复制引用

基金项目

国家自然科学基金(62272138)

出版年

2024
国际免疫学杂志
中华医学会 哈尔滨医科大学

国际免疫学杂志

CSTPCD
影响因子:0.774
ISSN:1673-4394
参考文献量32
段落导航相关论文